Eyenovia Inc. – an ophthalmic technology firm setting up the Optejet equipment f...
The FDA has raised concerns publicly following inspections of Eli Lilly and Rent...
Enzolytics, Inc., made an announcement recently that its wholly-owned subsidiary...
It is unclear if the first gene therapy for Duchenne muscular dystrophy will be ...
Pfizer and Valneva are delaying the regulatory filing of their Lyme disease vacc...
A study was published in the Proceedings of the National Academy of Sciences exp...
Travere Therapeutics is a startup that mainly focuses on rare forms of diseases....
Johnson & Johnson’s Janssen Biotech subsidiary has just paid $245 million upfron...
Eli Lilly’s injectable blood sugar drug, tirzepatide, which is currently being s...
Amgen has discontinued both of its mid-stage lupus programs due to a lack of eff...
Astellas Pharma has announced the acquisition of Iveric Bio for $5.9 billion, ba...
Sun Pharmaceutical Industries Ltd., an Indian firm, has been directed by the U.S...
Pfizer recently announced that its pneumococcal conjugate vaccine, Prevnar 20, h...
The FDA has granted conditional approval to a novel ALS medication, a move that ...
The FDA has approved Seres Therapeutics’ microbiome capsule, Vowst, to prevent t...
Despite winds blowing against the biotechnology industry in recent months, Orbit...
